| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transporter activity | NPC1 GABRG3 ATP6V1C1 TRPC7 TMC7 XKR9 TRPM7 SLC26A2 SLC6A17 TRPC3 SLC10A4 TRPC6 HCN3 TMEM63C ABCB6 SLC6A15 ATP10B ATP8B1 CHRNA2 SLC47A2 RYR1 ATP10D SLC7A9 CNNM4 SLC26A8 SLC25A12 KCNA10 SLC45A3 PKD1 ATP6V0A2 | 4.54e-09 | 1289 | 140 | 30 | GO:0005215 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | GABRG3 ATP6V1C1 TRPC7 TMC7 TRPM7 SLC26A2 TRPC3 SLC10A4 TRPC6 HCN3 TMEM63C SLC6A15 CHRNA2 SLC47A2 RYR1 CNNM4 SLC26A8 SLC25A12 KCNA10 SLC45A3 PKD1 ATP6V0A2 | 3.43e-08 | 793 | 140 | 22 | GO:0015075 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | GABRG3 ATP6V1C1 TRPC7 TRPM7 SLC26A2 TRPC3 SLC10A4 TRPC6 HCN3 TMEM63C SLC6A15 SLC47A2 RYR1 CNNM4 SLC26A8 SLC25A12 KCNA10 SLC45A3 PKD1 ATP6V0A2 | 3.42e-07 | 758 | 140 | 20 | GO:0015318 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | GABRG3 ATP6V1C1 TRPC7 TMC7 TRPM7 SLC26A2 SLC6A17 TRPC3 SLC10A4 TRPC6 HCN3 TMEM63C ABCB6 SLC6A15 CHRNA2 SLC47A2 RYR1 SLC7A9 CNNM4 SLC26A8 SLC25A12 KCNA10 SLC45A3 PKD1 ATP6V0A2 | 6.37e-07 | 1180 | 140 | 25 | GO:0022857 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | ATP6V1C1 TRPC7 TRPM7 TRPC3 SLC10A4 TRPC6 HCN3 TMEM63C SLC6A15 CHRNA2 SLC47A2 RYR1 CNNM4 SLC25A12 KCNA10 SLC45A3 PKD1 ATP6V0A2 | 9.51e-07 | 664 | 140 | 18 | GO:0008324 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | ATP6V1C1 TRPC7 TRPM7 TRPC3 SLC10A4 TRPC6 HCN3 TMEM63C SLC6A15 SLC47A2 RYR1 CNNM4 SLC25A12 KCNA10 SLC45A3 PKD1 ATP6V0A2 | 1.95e-06 | 627 | 140 | 17 | GO:0022890 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | GABRG3 TRPC7 TMC7 TRPM7 TRPC3 TRPC6 HCN3 TMEM63C CHRNA2 RYR1 SLC26A8 KCNA10 PKD1 | 2.14e-05 | 459 | 140 | 13 | GO:0005216 |
| GeneOntologyMolecularFunction | store-operated calcium channel activity | 7.09e-05 | 12 | 140 | 3 | GO:0015279 | |
| GeneOntologyMolecularFunction | channel activity | GABRG3 TRPC7 TMC7 TRPM7 TRPC3 TRPC6 HCN3 TMEM63C CHRNA2 RYR1 SLC26A8 KCNA10 PKD1 | 8.48e-05 | 525 | 140 | 13 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | GABRG3 TRPC7 TMC7 TRPM7 TRPC3 TRPC6 HCN3 TMEM63C CHRNA2 RYR1 SLC26A8 KCNA10 PKD1 | 8.64e-05 | 526 | 140 | 13 | GO:0022803 |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 1.16e-04 | 14 | 140 | 3 | GO:0070679 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ATP6V1C1 SLC26A2 SLC6A17 SLC10A4 ABCB6 SLC6A15 SLC47A2 SLC7A9 SLC26A8 SLC25A12 SLC45A3 ATP6V0A2 | 1.38e-04 | 477 | 140 | 12 | GO:0022804 |
| GeneOntologyMolecularFunction | glycosylceramide flippase activity | 1.46e-04 | 3 | 140 | 2 | GO:0140351 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | TRPC7 TRPM7 TRPC3 TRPC6 HCN3 TMEM63C CHRNA2 RYR1 KCNA10 PKD1 | 1.56e-04 | 343 | 140 | 10 | GO:0005261 |
| GeneOntologyMolecularFunction | flippase activity | 2.13e-04 | 17 | 140 | 3 | GO:0140327 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC26A2 SLC6A17 SLC10A4 SLC6A15 SLC47A2 SLC7A9 SLC26A8 SLC25A12 SLC45A3 | 2.46e-04 | 296 | 140 | 9 | GO:0015291 |
| GeneOntologyMolecularFunction | calcium channel activity | 2.99e-04 | 129 | 140 | 6 | GO:0005262 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DHX16 DNHD1 ATP6V1C1 ABCB6 ATP10B AK9 BTAF1 ATP8B1 ATP10D DNAH17 ACSF3 RAD54L ATP6V0A2 | 3.91e-04 | 614 | 140 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 4.30e-04 | 193 | 140 | 7 | GO:0015276 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | TRPC7 TRPM7 TRPC3 SLC10A4 TRPC6 HCN3 SLC6A15 RYR1 CNNM4 KCNA10 PKD1 | 4.44e-04 | 465 | 140 | 11 | GO:0046873 |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 4.48e-04 | 51 | 140 | 4 | GO:0140303 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 4.64e-04 | 140 | 140 | 6 | GO:0099094 | |
| GeneOntologyMolecularFunction | alkylglycerophosphoethanolamine phosphodiesterase activity | 4.81e-04 | 5 | 140 | 2 | GO:0047391 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 4.86e-04 | 197 | 140 | 7 | GO:0022834 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 6.91e-04 | 151 | 140 | 6 | GO:0015085 | |
| GeneOntologyMolecularFunction | phosphatidylcholine flippase activity | 7.19e-04 | 6 | 140 | 2 | GO:0140345 | |
| GeneOntologyMolecularFunction | alcohol binding | 7.62e-04 | 102 | 140 | 5 | GO:0043178 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 8.86e-04 | 61 | 140 | 4 | GO:1901682 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 9.72e-04 | 28 | 140 | 3 | GO:0140326 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | ATP6V1C1 SLC10A4 SLC6A15 SLC47A2 SLC26A8 SLC25A12 SLC45A3 ATP6V0A2 | 1.30e-03 | 301 | 140 | 8 | GO:0022853 |
| GeneOntologyMolecularFunction | dicarboxylic acid transmembrane transporter activity | 1.31e-03 | 31 | 140 | 3 | GO:0005310 | |
| GeneOntologyMolecularFunction | ribosome binding | 1.58e-03 | 120 | 140 | 5 | GO:0043022 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.58e-03 | 33 | 140 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | oxalate transmembrane transporter activity | 2.12e-03 | 10 | 140 | 2 | GO:0019531 | |
| GeneOntologyMolecularFunction | gated channel activity | 2.49e-03 | 334 | 140 | 8 | GO:0022836 | |
| GeneOntologyMolecularFunction | sulfur amino acid transmembrane transporter activity | 2.58e-03 | 11 | 140 | 2 | GO:0000099 | |
| GeneOntologyMolecularFunction | secondary active sulfate transmembrane transporter activity | 2.58e-03 | 11 | 140 | 2 | GO:0008271 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 2.62e-03 | 196 | 140 | 6 | GO:0005319 | |
| GeneOntologyMolecularFunction | antiporter activity | 2.90e-03 | 138 | 140 | 5 | GO:0015297 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 2.96e-03 | 41 | 140 | 3 | GO:0015175 | |
| GeneOntologyMolecularFunction | ribonucleoprotein complex binding | 3.35e-03 | 206 | 140 | 6 | GO:0043021 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 3.43e-03 | 207 | 140 | 6 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 3.51e-03 | 208 | 140 | 6 | GO:0005342 | |
| GeneOntologyMolecularFunction | intracellularly cyclic nucleotide-activated monoatomic cation channel activity | 3.62e-03 | 13 | 140 | 2 | GO:0005221 | |
| GeneOntologyMolecularFunction | cyclic nucleotide-activated monoatomic ion channel activity | 3.62e-03 | 13 | 140 | 2 | GO:0043855 | |
| GeneOntologyMolecularFunction | single-stranded DNA endodeoxyribonuclease activity | 3.62e-03 | 13 | 140 | 2 | GO:0000014 | |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 4.20e-03 | 14 | 140 | 2 | GO:0140333 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | GABRG3 ATP6V1C1 TRPC7 TMC7 TRPM7 SLC26A2 SLC6A17 TRPC3 TRPC6 HCN3 TMEM63C ABCB6 SLC6A15 ATP8B1 CHRNA2 SLC47A2 EDNRA RYR1 ATP10D CNNM4 SLC26A8 SLC25A12 KCNA10 PKD1 ATP6V0A2 | 9.02e-08 | 1115 | 138 | 25 | GO:0034220 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | GABRG3 ATP6V1C1 TRPC7 TMC7 TRPM7 SLC26A2 SLC6A17 TRPC3 SLC10A4 TRPC6 HCN3 TMEM63C CDH23 ABCB6 SLC6A15 ATP8B1 CHRNA2 SLC47A2 EDNRA RYR1 ATP10D CNNM4 SLC26A8 SLC25A12 KCNA10 PKD1 ATP6V0A2 | 3.62e-07 | 1374 | 138 | 27 | GO:0006811 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DCHS2 PRTG PCDHGA10 CDH23 PCDHA10 CELSR2 HMCN1 PKD1 CDH2 PCDH18 | 5.35e-07 | 187 | 138 | 10 | GO:0007156 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | GABRG3 ATP6V1C1 TRPC7 TRPM7 SLC26A2 SLC6A17 TRPC3 TRPC6 HCN3 ABCB6 SLC6A15 SLC47A2 EDNRA RYR1 CNNM4 SLC26A8 SLC25A12 KCNA10 PKD1 ATP6V0A2 | 1.44e-05 | 1017 | 138 | 20 | GO:0098660 |
| GeneOntologyBiologicalProcess | pigmentation | 2.13e-05 | 125 | 138 | 7 | GO:0043473 | |
| GeneOntologyBiologicalProcess | regulation of cytosolic calcium ion concentration | 2.13e-05 | 84 | 138 | 6 | GO:0051480 | |
| GeneOntologyBiologicalProcess | negative regulation of telomere capping | 2.39e-05 | 9 | 138 | 3 | GO:1904354 | |
| GeneOntologyBiologicalProcess | multi-pass transmembrane protein insertion into ER membrane | 2.39e-05 | 9 | 138 | 3 | GO:0160063 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | ATP6V1C1 TRPC7 TRPM7 SLC6A17 TRPC3 SLC10A4 TRPC6 HCN3 TMEM63C CDH23 ABCB6 SLC6A15 SLC47A2 EDNRA RYR1 ATP10D CNNM4 SLC25A12 KCNA10 PKD1 ATP6V0A2 | 2.84e-05 | 1157 | 138 | 21 | GO:0006812 |
| GeneOntologyBiologicalProcess | developmental pigmentation | 4.30e-05 | 58 | 138 | 5 | GO:0048066 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DCHS2 PRTG PCDHGA10 CDH23 PCDHA10 CELSR2 HMCN1 PKD1 CDH2 PCDH18 | 5.00e-05 | 313 | 138 | 10 | GO:0098742 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | ATP6V1C1 TRPC7 TRPM7 SLC6A17 TRPC3 TRPC6 HCN3 TMEM63C ABCB6 SLC6A15 SLC47A2 EDNRA RYR1 CNNM4 SLC25A12 KCNA10 PKD1 ATP6V0A2 | 5.83e-05 | 942 | 138 | 18 | GO:0098655 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | ATP6V1C1 TRPC7 TRPM7 SLC6A17 TRPC3 TRPC6 HCN3 ABCB6 SLC6A15 SLC47A2 EDNRA RYR1 CNNM4 SLC25A12 KCNA10 PKD1 ATP6V0A2 | 1.46e-04 | 922 | 138 | 17 | GO:0098662 |
| GeneOntologyBiologicalProcess | phospholipid homeostasis | 2.22e-04 | 18 | 138 | 3 | GO:0055091 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | TRPC7 TRPM7 TRPC3 TRPC6 VPS33A CDH23 ABCB6 ADCY8 EDNRA RYR1 CNNM4 PKHD1 ATP6V0A2 | 2.38e-04 | 611 | 138 | 13 | GO:0030003 |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | TRPC7 TRPM7 TRPC3 TRPC6 VPS33A CDH23 ABCB6 ADCY8 EDNRA RYR1 CNNM4 PKHD1 ATP6V0A2 | 2.83e-04 | 622 | 138 | 13 | GO:0006873 |
| GeneOntologyCellularComponent | transporter complex | GABRG3 ATP6V1C1 TRPC7 TRPC3 TRPC6 HCN3 ABCB6 ATP10B ATP8B1 CHRNA2 RYR1 ATP10D KCNA10 CPT1C PKD1 ATP6V0A2 | 8.96e-07 | 550 | 140 | 16 | GO:1990351 |
| GeneOntologyCellularComponent | multi-pass translocon complex | 2.40e-05 | 9 | 140 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | GABRG3 ATP6V1C1 TRPC7 TRPC3 TRPC6 HCN3 ABCB6 CHRNA2 RYR1 KCNA10 CPT1C PKD1 ATP6V0A2 | 5.16e-05 | 523 | 140 | 13 | GO:1902495 |
| GeneOntologyCellularComponent | ER membrane insertion complex | 1.01e-04 | 14 | 140 | 3 | GO:0072379 | |
| GeneOntologyCellularComponent | phospholipid-translocating ATPase complex | 1.01e-04 | 14 | 140 | 3 | GO:1990531 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 2.37e-04 | 378 | 140 | 10 | GO:0034702 | |
| GeneOntologyCellularComponent | membrane protein complex | GABRG3 ATP6V1C1 TRPC7 TRPC3 TRPC6 HCN3 VPS33A CDH23 ABCB6 ITGA1 ITGB6 CHRNA2 RYR1 SCAP KCNA10 CPT1C AP5B1 PKD1 GNA11 RNF139 CDH2 ATP6V0A2 | 4.00e-04 | 1498 | 140 | 22 | GO:0098796 |
| GeneOntologyCellularComponent | extrinsic component of membrane | 9.28e-04 | 230 | 140 | 7 | GO:0019898 | |
| GeneOntologyCellularComponent | cation channel complex | 1.05e-03 | 235 | 140 | 7 | GO:0034703 | |
| Domain | DUF2012 | 1.50e-06 | 4 | 136 | 3 | PF09430 | |
| Domain | DUF2012 | 1.50e-06 | 4 | 136 | 3 | IPR019008 | |
| Domain | TRP_2 | 7.43e-06 | 6 | 136 | 3 | PF08344 | |
| Domain | TRP_dom | 7.43e-06 | 6 | 136 | 3 | IPR013555 | |
| Domain | TRPC_channel | 1.29e-05 | 7 | 136 | 3 | IPR002153 | |
| Domain | Cadherin_CS | 1.49e-05 | 109 | 136 | 7 | IPR020894 | |
| Domain | CADHERIN_1 | 1.89e-05 | 113 | 136 | 7 | PS00232 | |
| Domain | Cadherin | 1.89e-05 | 113 | 136 | 7 | PF00028 | |
| Domain | Ion_trans_dom | 2.00e-05 | 114 | 136 | 7 | IPR005821 | |
| Domain | Ion_trans | 2.00e-05 | 114 | 136 | 7 | PF00520 | |
| Domain | CADHERIN_2 | 2.00e-05 | 114 | 136 | 7 | PS50268 | |
| Domain | - | 2.00e-05 | 114 | 136 | 7 | 2.60.40.60 | |
| Domain | Carb-bd-like_fold | 2.06e-05 | 8 | 136 | 3 | IPR013784 | |
| Domain | CA | 2.12e-05 | 115 | 136 | 7 | SM00112 | |
| Domain | Cadherin-like | 2.24e-05 | 116 | 136 | 7 | IPR015919 | |
| Domain | Cadherin | 2.50e-05 | 118 | 136 | 7 | IPR002126 | |
| Domain | TRP_channel | 5.97e-05 | 11 | 136 | 3 | IPR004729 | |
| Domain | CarboxyPept_regulatory_dom | 1.02e-04 | 13 | 136 | 3 | IPR014766 | |
| Domain | - | 1.02e-04 | 13 | 136 | 3 | 2.60.40.1120 | |
| Domain | P_typ_ATPase_c | 1.30e-04 | 14 | 136 | 3 | IPR032630 | |
| Domain | P-type_ATPase_N | 1.30e-04 | 14 | 136 | 3 | IPR032631 | |
| Domain | P-type_ATPase_IV | 1.30e-04 | 14 | 136 | 3 | IPR006539 | |
| Domain | PhoLip_ATPase_C | 1.30e-04 | 14 | 136 | 3 | PF16212 | |
| Domain | PhoLip_ATPase_N | 1.30e-04 | 14 | 136 | 3 | PF16209 | |
| Domain | CarboxyPept-like_regulatory | 2.38e-04 | 17 | 136 | 3 | IPR008969 | |
| Domain | VWFA | 3.31e-04 | 82 | 136 | 5 | PS50234 | |
| Domain | VWA | 3.70e-04 | 84 | 136 | 5 | SM00327 | |
| Domain | Sterol-sensing | 5.19e-04 | 5 | 136 | 2 | PF12349 | |
| Domain | Na/ntran_symport_orphan | 5.19e-04 | 5 | 136 | 2 | IPR002438 | |
| Domain | Alpha_kinase | 7.75e-04 | 6 | 136 | 2 | PF02816 | |
| Domain | MHCK_EF2_kinase | 7.75e-04 | 6 | 136 | 2 | IPR004166 | |
| Domain | ALPHA_KINASE | 7.75e-04 | 6 | 136 | 2 | PS51158 | |
| Domain | Alpha_kinase | 7.75e-04 | 6 | 136 | 2 | SM00811 | |
| Domain | VWF_A | 7.86e-04 | 99 | 136 | 5 | IPR002035 | |
| Domain | - | 1.60e-03 | 32 | 136 | 3 | 3.40.1110.10 | |
| Domain | - | 1.60e-03 | 32 | 136 | 3 | 2.70.150.10 | |
| Domain | GPS | 1.92e-03 | 34 | 136 | 3 | SM00303 | |
| Domain | ATPase_P-typ_cyto_domN | 2.08e-03 | 35 | 136 | 3 | IPR023299 | |
| Domain | GPS | 2.08e-03 | 35 | 136 | 3 | PF01825 | |
| Domain | - | 2.09e-03 | 74 | 136 | 4 | 3.40.50.410 | |
| Domain | ATPase_P-typ_P_site | 2.26e-03 | 36 | 136 | 3 | IPR018303 | |
| Domain | P_typ_ATPase | 2.26e-03 | 36 | 136 | 3 | IPR001757 | |
| Domain | GPS | 2.26e-03 | 36 | 136 | 3 | PS50221 | |
| Domain | ATPASE_E1_E2 | 2.26e-03 | 36 | 136 | 3 | PS00154 | |
| Domain | SLC26A | 2.28e-03 | 10 | 136 | 2 | PS01130 | |
| Domain | Hydrolase_3 | 2.28e-03 | 10 | 136 | 2 | PF08282 | |
| Domain | ATPase_P-typ_transduc_dom_A | 2.45e-03 | 37 | 136 | 3 | IPR008250 | |
| Domain | GPS | 2.45e-03 | 37 | 136 | 3 | IPR000203 | |
| Domain | E1-E2_ATPase | 2.45e-03 | 37 | 136 | 3 | PF00122 | |
| Domain | STAS | 2.77e-03 | 11 | 136 | 2 | PS50801 | |
| Domain | STAS | 2.77e-03 | 11 | 136 | 2 | PF01740 | |
| Domain | SLC26A/SulP_fam | 2.77e-03 | 11 | 136 | 2 | IPR001902 | |
| Domain | STAS_dom | 2.77e-03 | 11 | 136 | 2 | IPR002645 | |
| Domain | SLC26A/SulP_dom | 2.77e-03 | 11 | 136 | 2 | IPR011547 | |
| Domain | - | 2.77e-03 | 11 | 136 | 2 | 3.30.750.24 | |
| Domain | Sulfate_transp | 2.77e-03 | 11 | 136 | 2 | PF00916 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | ATP6V1C1 TRPC7 TRPM7 TRPC3 TRPC6 ATP10B ATP8B1 RYR1 ATP10D ATP6V0A2 | 8.07e-07 | 176 | 106 | 10 | MM15718 |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | ATP6V1C1 TRPC7 TRPM7 TRPC3 TRPC6 ATP10B ATP8B1 RYR1 ATP10D ATP6V0A2 | 1.15e-06 | 183 | 106 | 10 | M997 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | NPC1 ATP6V1C1 TRPC7 TRPM7 SLC26A2 TRPC3 TRPC6 ABCB6 SLC6A15 ATP10B ATP8B1 SLC47A2 ADCY8 RYR1 ATP10D SLC7A9 SLC45A3 ATP6V0A2 | 8.58e-06 | 736 | 106 | 18 | M27287 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | NPC1 ATP6V1C1 TRPC7 TRPM7 SLC26A2 TRPC3 TRPC6 ABCB6 SLC6A15 ATP10B ATP8B1 RYR1 ATP10D SLC7A9 SLC45A3 ATP6V0A2 | 4.68e-05 | 681 | 106 | 16 | MM14985 |
| Pathway | REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN_1_SIGNALING | 4.77e-05 | 10 | 106 | 3 | M27330 | |
| Pathway | REACTOME_TRP_CHANNELS | 5.38e-05 | 28 | 106 | 4 | MM14943 | |
| Pathway | REACTOME_TRP_CHANNELS | 5.38e-05 | 28 | 106 | 4 | M27241 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 1.12e-04 | 13 | 106 | 3 | MM14553 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 2.16e-04 | 16 | 106 | 3 | M26945 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.64e-04 | 76 | 106 | 5 | MM14867 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 4.45e-04 | 85 | 106 | 5 | M16441 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MCMBP GPAM ICE1 BIRC6 RYR1 PRDM2 DOCK5 RNF123 DST RPAP1 TBK1 PKD1 VPS13A PLXNA4 PKHD1 ATM | 5.16e-08 | 736 | 140 | 16 | 29676528 |
| Pubmed | 5.18e-08 | 10 | 140 | 4 | 27177420 | ||
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 36011023 | ||
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 28526717 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 6.38e-08 | 3 | 140 | 3 | 25576386 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NPC1 MFHAS1 LAMA5 ICE1 BTAF1 BIRC6 LYST RYR1 TBC1D17 ARHGEF40 SCAP DST RPAP1 CELSR2 SLC45A3 PKD1 NCAPD2 ULK4 SMG6 | 1.08e-07 | 1105 | 140 | 19 | 35748872 |
| Pubmed | 2.13e-07 | 33 | 140 | 5 | 19834762 | ||
| Pubmed | 2.55e-07 | 4 | 140 | 3 | 30017393 | ||
| Pubmed | 2.55e-07 | 4 | 140 | 3 | 22566504 | ||
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 2.55e-07 | 4 | 140 | 3 | 31833031 | |
| Pubmed | 2.55e-07 | 4 | 140 | 3 | 9267806 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | NPC1 NOC2L SLC6A15 BTAF1 GALNT7 CNNM4 ARHGEF40 SCAP SLC25A12 NUP155 RPAP1 FAM171A2 TBK1 NUP210 CLPTM1 NCAPD2 NOMO3 | 2.72e-07 | 942 | 140 | 17 | 31073040 |
| Pubmed | DHX16 XRN2 ERCC4 GPAM BTAF1 SYDE1 TBC1D17 DOCK5 ARHGEF40 DST NUP155 RPAP1 AP5B1 TBK1 | 4.14e-07 | 650 | 140 | 14 | 38777146 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 4.44e-07 | 38 | 140 | 5 | 30786075 | |
| Pubmed | 5.75e-07 | 17 | 140 | 4 | 22411552 | ||
| Pubmed | 6.35e-07 | 5 | 140 | 3 | 21261756 | ||
| Pubmed | TRPC channels are necessary mediators of pathologic cardiac hypertrophy. | 6.35e-07 | 5 | 140 | 3 | 20351294 | |
| Pubmed | 9.42e-07 | 44 | 140 | 5 | 19322198 | ||
| Pubmed | 1.27e-06 | 6 | 140 | 3 | 25947375 | ||
| Pubmed | 1.43e-06 | 21 | 140 | 4 | 30270038 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | NPC1 NR2C2 COL7A1 LAMA5 ADGRG1 SLC6A15 ITGA1 GALNT7 NOMO1 SCAP CELSR2 NOMO2 NUP210 CLPTM1 ATM CDH2 DGAT1 ATP6V0A2 | 1.72e-06 | 1201 | 140 | 18 | 35696571 |
| Pubmed | MxA, a member of the dynamin superfamily, interacts with the ankyrin-like repeat domain of TRPC. | 2.21e-06 | 7 | 140 | 3 | 15757897 | |
| Pubmed | 2.21e-06 | 7 | 140 | 3 | 36592529 | ||
| Pubmed | Functional role of TRPC proteins in vivo: lessons from TRPC-deficient mouse models. | 2.21e-06 | 7 | 140 | 3 | 15336983 | |
| Pubmed | 2.21e-06 | 7 | 140 | 3 | 32350291 | ||
| Pubmed | 2.21e-06 | 7 | 140 | 3 | 38835669 | ||
| Pubmed | 2.21e-06 | 7 | 140 | 3 | 36257322 | ||
| Pubmed | Mapping the expression of transient receptor potential channels across murine placental development. | 2.51e-06 | 24 | 140 | 4 | 33884443 | |
| Pubmed | 2.98e-06 | 25 | 140 | 4 | 16382100 | ||
| Pubmed | 3.52e-06 | 8 | 140 | 3 | 25471572 | ||
| Pubmed | 3.52e-06 | 8 | 140 | 3 | 15199065 | ||
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 3.52e-06 | 8 | 140 | 3 | 15257293 | |
| Pubmed | Subunit composition of mammalian transient receptor potential channels in living cells. | 3.52e-06 | 8 | 140 | 3 | 12032305 | |
| Pubmed | 4.11e-06 | 27 | 140 | 4 | 16460286 | ||
| Pubmed | 5.27e-06 | 9 | 140 | 3 | 17480026 | ||
| Pubmed | 5.27e-06 | 9 | 140 | 3 | 15623527 | ||
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 5.27e-06 | 9 | 140 | 3 | 36261522 | |
| Pubmed | 5.27e-06 | 9 | 140 | 3 | 11290752 | ||
| Pubmed | NPC1 TRPM7 SLC26A2 VPS33A SLC6A15 LYST SCAP DST NUP155 COG6 VPS13A | 6.71e-06 | 504 | 140 | 11 | 34432599 | |
| Pubmed | DHX16 MCMBP NOMO1 SLC25A12 NUP155 RPAP1 NOMO2 TBK1 NUP210 NCAPD2 VPS13A NOMO3 | 6.77e-06 | 606 | 140 | 12 | 36538041 | |
| Pubmed | Heterogeneous distribution of TRPC proteins in the embryonic cortex. | 7.50e-06 | 10 | 140 | 3 | 18989690 | |
| Pubmed | An ER translocon for multi-pass membrane protein biogenesis. | 1.03e-05 | 11 | 140 | 3 | 32820719 | |
| Pubmed | 1.27e-05 | 126 | 140 | 6 | 17897319 | ||
| Pubmed | 1.37e-05 | 12 | 140 | 3 | 21914794 | ||
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | COL7A1 NOC2L ENPP2 ALPK1 LYST RYR1 PRDM2 DOCK5 VPS13A ULK4 NOMO3 | 1.57e-05 | 552 | 140 | 11 | 10737800 |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 9245798 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 22724068 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 32140760 | ||
| Pubmed | [Mechanism of cardiac hypertrophy via diacylglycerol-sensitive TRPC channels]. | 1.61e-05 | 2 | 140 | 2 | 20190513 | |
| Pubmed | Synaptic Vesicle Protein NTT4/XT1 (SLC6A17) Catalyzes Na+-coupled Neutral Amino Acid Transport. | 1.61e-05 | 2 | 140 | 2 | 19147495 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 11919560 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 23529130 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 33333171 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 33802342 | ||
| Pubmed | N-linked protein glycosylation is a major determinant for basal TRPC3 and TRPC6 channel activity. | 1.61e-05 | 2 | 140 | 2 | 12970363 | |
| Pubmed | PLC-mediated PI(4,5)P2 hydrolysis regulates activation and inactivation of TRPC6/7 channels. | 1.61e-05 | 2 | 140 | 2 | 24470487 | |
| Pubmed | Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. | 1.61e-05 | 2 | 140 | 2 | 9930701 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 24453217 | ||
| Pubmed | Enteroendocrine cells are a potential source of serum autotaxin in men. | 1.61e-05 | 2 | 140 | 2 | 26775031 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 18215135 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 28968864 | ||
| Pubmed | Pathogenicity analysis of novel variations in Chinese Han patients with polycystic kidney disease. | 1.61e-05 | 2 | 140 | 2 | 28578020 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 25213992 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 27861908 | ||
| Pubmed | Structure of the receptor-activated human TRPC6 and TRPC3 ion channels. | 1.61e-05 | 2 | 140 | 2 | 29700422 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 29661922 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 23800468 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 28105583 | ||
| Pubmed | Functional coupling between TRPC3 and RyR1 regulates the expressions of key triadic proteins. | 1.61e-05 | 2 | 140 | 2 | 16484216 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 35051376 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 36293397 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 22306362 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 19749484 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 9368034 | ||
| Pubmed | Type VII collagen is required for Ras-driven human epidermal tumorigenesis. | 1.61e-05 | 2 | 140 | 2 | 15774758 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 34504016 | ||
| Pubmed | A TRPC3/6 Channel Inhibitor Promotes Arteriogenesis after Hind-Limb Ischemia. | 1.61e-05 | 2 | 140 | 2 | 35805125 | |
| Pubmed | 1.77e-05 | 13 | 140 | 3 | 22051675 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.88e-05 | 202 | 140 | 7 | 33005030 | |
| Pubmed | NR2C2 MCMBP TRPM7 NOC2L SLC6A15 TBC1D17 NOMO1 GUF1 NUP155 RPAP1 FAM171A2 UTP15 NOMO2 NUP210 CLPTM1 VPS13A ATM ATP6V0A2 | 3.11e-05 | 1487 | 140 | 18 | 33957083 | |
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 24905090 | ||
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 28790356 | ||
| Pubmed | Characterization of PKD protein-positive exosome-like vesicles. | 4.81e-05 | 3 | 140 | 2 | 19158352 | |
| Pubmed | Selective association of TRPC channel subunits in rat brain synaptosomes. | 4.81e-05 | 3 | 140 | 2 | 12377790 | |
| Pubmed | Functional coupling of G proteins to endothelin receptors is ligand and receptor subtype specific. | 4.81e-05 | 3 | 140 | 2 | 10789830 | |
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 15972814 | ||
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 23938296 | ||
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 19061978 | ||
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 15358862 | ||
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 21757714 | ||
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 30563842 | ||
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 21865467 | ||
| Pubmed | Orai proteins interact with TRPC channels and confer responsiveness to store depletion. | 4.81e-05 | 3 | 140 | 2 | 17360584 | |
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 19812035 | ||
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 35396331 | ||
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 19074769 | ||
| Pubmed | High-Throughput Sequencing Identifies 3 Novel Susceptibility Genes for Hereditary Melanoma. | 4.81e-05 | 3 | 140 | 2 | 32276436 | |
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 32097940 | ||
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 17616673 | ||
| Pubmed | Analysis of the polycystin complex (PCC) in human urinary exosome-like vesicles (ELVs). | 4.81e-05 | 3 | 140 | 2 | 32001768 | |
| Interaction | TRPC7 interactions | 5.67e-06 | 6 | 134 | 3 | int:TRPC7 | |
| GeneFamily | Transient receptor potential cation channels | 1.27e-05 | 28 | 94 | 4 | 249 | |
| GeneFamily | ATPase phospholipid transporting | 5.92e-05 | 15 | 94 | 3 | 1210 | |
| GeneFamily | Solute carriers | SLC26A2 SLC6A17 SLC10A4 SLC6A15 SLC47A2 SLC7A9 SLC26A8 SLC25A12 SLC45A3 | 2.14e-04 | 395 | 94 | 9 | 752 |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 5.91e-10 | 193 | 140 | 10 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-08 | 192 | 140 | 9 | 158cc5736f154da1cb3186ffbf186eae10483e48 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-08 | 192 | 140 | 9 | f4ff62ac9c53eafbe917706de9af8b2d4bded4d4 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.15e-08 | 194 | 140 | 9 | d9eec28fa7b255c0ec023276dd955f1e276e7159 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.15e-08 | 194 | 140 | 9 | e4d7e9709ce42d4610e44d3445927eefbcbb9eff | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.88e-08 | 173 | 140 | 8 | f9d6e892d66f9b94e4d5beb9f5dec9b606bc868a | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.88e-08 | 173 | 140 | 8 | cbd65dd5b01cc959e3ccbc89330ddd0122296ea3 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.61e-08 | 175 | 140 | 8 | 2a53d4f140d5ab096efe8118d8aa351db7838b49 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.61e-08 | 175 | 140 | 8 | fb91a45763e4c48d993094a13088ffc19f1e2574 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.99e-08 | 176 | 140 | 8 | e2b59a904c5c8f9c88e1e63788e9b6485f22edd0 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.99e-08 | 176 | 140 | 8 | f931192e3cc65414e2245354f443473696cc7ce8 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.40e-08 | 177 | 140 | 8 | 65709bd546cb1ec6aa2ddd8b2adb46e174eb9a9a | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.40e-08 | 177 | 140 | 8 | 8684d47a547e2a06496f15e8da0200ecddc431e0 | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.81e-08 | 178 | 140 | 8 | 8bae5db100f4563aa1fc7f881e7f8c59d669e37a | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.81e-08 | 178 | 140 | 8 | bc0336692b84bd0fa49747ed5a031b8ed8afa0fd | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.02e-07 | 179 | 140 | 8 | f5bb4d3a27d56698473219970e764084096cc582 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-07 | 179 | 140 | 8 | 7078022e60faa86444f2a2c6eb9f767cc66b5cfa | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.02e-07 | 179 | 140 | 8 | fa03ec3cc0132f977b4cb28e7b23789732375183 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-07 | 179 | 140 | 8 | 56db12467b445f2b8ef92af50779eeab10413eb2 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-07 | 179 | 140 | 8 | d4a975d8ffa5e77fb5c0ec05bf9c8f843c77ce07 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-07 | 180 | 140 | 8 | f6a05b3751b01e74b2de8440801b0eb2e723c199 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-07 | 180 | 140 | 8 | dfc75ae4395ff46fbec2c54915d98ead5a1ba1a1 | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.12e-07 | 181 | 140 | 8 | dff264815a3569f5666d0bbc3867c0496cd78774 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-07 | 182 | 140 | 8 | 9edaccf1154cec92ca9a28e9b1f9075cfd422bfd | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-07 | 182 | 140 | 8 | aba4c06d5d7618ac21b2695bca8e7a1346a91090 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.27e-07 | 184 | 140 | 8 | 55dde9c4eebac2a33788c1ff1d8fe312d150fad4 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.27e-07 | 184 | 140 | 8 | 4cb5f299dd7413e0be1ad7af817ee614b23a18ae | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.27e-07 | 184 | 140 | 8 | 7128a2be291544d3df3ed6c80f21ddda8437dcba | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.27e-07 | 184 | 140 | 8 | d14238f7b0b55a4c8d7040bea854bd221a66ac30 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-myofibroblast-pericyte_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.27e-07 | 184 | 140 | 8 | 39bb0eb55bdc2cea46e41c7f21d8c5883f14e6bd | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.56e-07 | 189 | 140 | 8 | ca3a04c202afc32aa11d17154066ef7dc6d01405 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.62e-07 | 190 | 140 | 8 | 1004e89d99c9d46c78b7d3532d8d4aadb81a96fd | |
| ToppCell | droplet-Lung-1m-Mesenchymal-myofibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.75e-07 | 192 | 140 | 8 | dc4b4e16e6eb212e45fb70695afd1c7e91027407 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.90e-07 | 194 | 140 | 8 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.98e-07 | 195 | 140 | 8 | 4a5d2f62aad5817d077177bf8b4ff0e46d3b8d97 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.98e-07 | 195 | 140 | 8 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.98e-07 | 195 | 140 | 8 | 7a32a8535c29b819dacba901d0658280a2631c94 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 6.71e-07 | 157 | 140 | 7 | 2c1219ee19a6246a3b9f5c2c1a37f26ea934a822 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.19e-06 | 171 | 140 | 7 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.24e-06 | 172 | 140 | 7 | e9095c3dac66cf93d31f5f88364b565abacb1e2d | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-06 | 175 | 140 | 7 | d2ff8fedca9039cbd45cfd9dec88f4edbe7fe4fc | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-06 | 175 | 140 | 7 | a7310950e8d51b3004ea3aee8ce9948fe8655112 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.50e-06 | 177 | 140 | 7 | 2b63f0529ef73e0eede9b7ef1f08b0a0426a9c82 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-06 | 179 | 140 | 7 | bfc226bcf0b93525992344f968268a261d86fcbf | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-06 | 179 | 140 | 7 | 36ad18f52e175ab636ceaa3be81212fa362c96c1 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-06 | 180 | 140 | 7 | 0153667e44fdbc3c0d444dcb023069925a2b69a2 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-06 | 180 | 140 | 7 | 40a28b410f46215d6d7cf8a02a18078eb046b5b0 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.74e-06 | 181 | 140 | 7 | 274c0b768925cd5804483303f8c5ebd17a534c41 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.74e-06 | 181 | 140 | 7 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.01e-06 | 185 | 140 | 7 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.01e-06 | 185 | 140 | 7 | b1e84228c95be8ccf7c3c1afb66b71ffb93cf61e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.08e-06 | 186 | 140 | 7 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.16e-06 | 187 | 140 | 7 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 2.16e-06 | 187 | 140 | 7 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 2.16e-06 | 187 | 140 | 7 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-06 | 187 | 140 | 7 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.16e-06 | 187 | 140 | 7 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.24e-06 | 188 | 140 | 7 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 2.24e-06 | 188 | 140 | 7 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 2.32e-06 | 189 | 140 | 7 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.40e-06 | 190 | 140 | 7 | 7e4d80a3a7f83b6a50f1d0fe82fb6c242c39d5b0 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.40e-06 | 190 | 140 | 7 | 10125091ad648163777b02e9f0d5e8d7f17d44a5 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.40e-06 | 190 | 140 | 7 | 7fec459cd2ad12c2923a03d098289337c0a4c1d3 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.40e-06 | 190 | 140 | 7 | 10b02c62e72bfea9767e3e751011436925da823e | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.48e-06 | 191 | 140 | 7 | ddbc5f97f2aef19be4ad93db4139876c939b848e | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.57e-06 | 192 | 140 | 7 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.75e-06 | 194 | 140 | 7 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.75e-06 | 194 | 140 | 7 | 8f19e553f18c313c2a2ff9453884b9484b255d71 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.75e-06 | 194 | 140 | 7 | 67fbb81b7d20cb63be27b2a2beea5b5689f8e08c | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.75e-06 | 194 | 140 | 7 | f95935153bd2c4c3c7b2b729da6f7e98b45fed79 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-06 | 195 | 140 | 7 | 938b31dbf1674ee6fd0123bc88391ddcaf151217 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.85e-06 | 195 | 140 | 7 | 2eed0332e338d6f0dbcb399d9d36c4611d491b0a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-06 | 195 | 140 | 7 | d39e9e6544f49e677ebe528c6fe60b99a3630e30 | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.95e-06 | 196 | 140 | 7 | c373465e34e2dd581247962d59e0477aae877079 | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.95e-06 | 196 | 140 | 7 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.95e-06 | 196 | 140 | 7 | 8b5337ccf74de90e8b89a02ac00671af1de2cfff | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.95e-06 | 196 | 140 | 7 | 6708026bafd19c35c5c4e81911344d36a0f508cd | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.05e-06 | 197 | 140 | 7 | f66945f9007d59d4208849c7fd727f8519713fbc | |
| ToppCell | Basal_cells|World / lung cells shred on cell class, cell subclass, sample id | 3.05e-06 | 197 | 140 | 7 | 24360b660000bdfb999d58fbf4e29585a97e1785 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.05e-06 | 197 | 140 | 7 | 63b63c6b2f842adb87bc83222ff86796bd9b58f6 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.05e-06 | 197 | 140 | 7 | fb50903b87498b400c8e16e6a561b6d9458e5d97 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.05e-06 | 197 | 140 | 7 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 3.26e-06 | 199 | 140 | 7 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.26e-06 | 199 | 140 | 7 | 929f809579368201331d9099d8904b6e3c41797b | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.26e-06 | 199 | 140 | 7 | 854628ce91068093c14bd4d45ba38c41469f3549 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.37e-06 | 200 | 140 | 7 | a9cdddc4e985dae59521e557479c24fcc2ac727d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.37e-06 | 200 | 140 | 7 | 2f481e2fd248c02a5aa2e0248c16808df142fed2 | |
| ToppCell | proximal-3-mesenchymal-Pericyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.37e-06 | 200 | 140 | 7 | 98cbd0f4994e645f70c0bc5ebc1c3a3b28c6b67f | |
| ToppCell | distal-3-mesenchymal-Pericyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.37e-06 | 200 | 140 | 7 | 911db29f254bb697610e720ba78816e2c7f57933 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-06 | 200 | 140 | 7 | d70bad979299615fcba707ba21296020918705e6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.37e-06 | 200 | 140 | 7 | bd4b9f6b37f4a3c960c4149cf0cfd2caf3327d2d | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6--L3-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.37e-06 | 200 | 140 | 7 | 33b9199e0dfc267e2cea20b82d1c167f8adcc635 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-06 | 200 | 140 | 7 | 38c21ec379005f688df33aea65237a063c476c2e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.37e-06 | 200 | 140 | 7 | dc674124475edf83908b51a4e1454bc2dc4f06fa | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte|Control_saline / Treatment groups by lineage, cell group, cell type | 3.37e-06 | 200 | 140 | 7 | cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.37e-06 | 200 | 140 | 7 | 9719fabddc34051949468a7520289e3c750de4f8 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 3.37e-06 | 200 | 140 | 7 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| ToppCell | proximal-mesenchymal-Pericyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.37e-06 | 200 | 140 | 7 | 03119a979bc912a98e6fc87addcbc25d8ecf2fb0 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 3.37e-06 | 200 | 140 | 7 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | proximal-mesenchymal-Pericyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.37e-06 | 200 | 140 | 7 | a81fde3d40b8efb3be535aeb2a44cfbdeb17bc8b | |
| Computational | Ion channels. | 3.40e-05 | 27 | 75 | 4 | MODULE_214 | |
| Drug | beta- Belladonnine dichloroethylate [191355-47-2]; Down 200; 6uM; MCF7; HT_HG-U133A | ATP6V1C1 CYP20A1 ALPK1 EDNRA TBC1D17 DOCK5 RPAP1 NUP210 VPS13A ATM | 3.86e-07 | 196 | 140 | 10 | 4984_DN |
| Disease | nicotine dependence (implicated_via_orthology) | 2.09e-05 | 12 | 137 | 3 | DOID:0050742 (implicated_via_orthology) | |
| Disease | progressive familial intrahepatic cholestasis (implicated_via_orthology) | 6.40e-05 | 3 | 137 | 2 | DOID:0070221 (implicated_via_orthology) | |
| Disease | progranulin measurement | 1.41e-04 | 22 | 137 | 3 | EFO_0004625 | |
| Disease | C-reactive protein measurement | NPC1 DCHS2 MFHAS1 SLC6A15 GPRC6A CCDC168 ITGA1 PTBP1 IL22RA1 ADCY8 CELSR2 DNAH17 CLPTM1 PKD1 LRMDA ANKS1A | 1.56e-04 | 1206 | 137 | 16 | EFO_0004458 |
| Disease | melanoma | 1.66e-04 | 248 | 137 | 7 | C0025202 | |
| Disease | nephrotic syndrome (biomarker_via_orthology) | 1.85e-04 | 24 | 137 | 3 | DOID:1184 (biomarker_via_orthology) | |
| Disease | pulmonary hypertension (is_marker_for) | 2.28e-04 | 64 | 137 | 4 | DOID:6432 (is_marker_for) | |
| Disease | magnesium measurement | 2.56e-04 | 66 | 137 | 4 | EFO_0004845 | |
| Disease | urate measurement, bone density | NR2C2 ERCC4 TRPC6 LAMA5 COL6A5 ITGB6 DOCK5 SLC26A8 PLXNA4 LRMDA | 6.50e-04 | 619 | 137 | 10 | EFO_0003923, EFO_0004531 |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 6.52e-04 | 148 | 137 | 5 | C0279702 | |
| Disease | intermediate density lipoprotein measurement | 7.35e-04 | 87 | 137 | 4 | EFO_0008595 | |
| Disease | fibrinogen measurement, coronary artery disease | 7.79e-04 | 154 | 137 | 5 | EFO_0001645, EFO_0004623 | |
| Disease | thioredoxin domain-containing protein 12 measurement | 7.92e-04 | 39 | 137 | 3 | EFO_0008298 | |
| Disease | quality of life during menstruation measurement, aggressive behavior | 9.40e-04 | 10 | 137 | 2 | EFO_0003015, EFO_0009366 | |
| Disease | atopic eczema, childhood onset asthma, atopic march | 1.15e-03 | 11 | 137 | 2 | EFO_0000274, EFO_0007755, MONDO_0005405 | |
| Disease | aortic measurement | 1.16e-03 | 251 | 137 | 6 | EFO_0020865 | |
| Disease | phospholipid measurement, intermediate density lipoprotein measurement | 1.19e-03 | 99 | 137 | 4 | EFO_0004639, EFO_0008595 | |
| Disease | complement C1q tumor necrosis factor-related protein 1 measurement | 1.37e-03 | 12 | 137 | 2 | EFO_0801493 | |
| Disease | granulins measurement | 1.37e-03 | 12 | 137 | 2 | EFO_0008141 | |
| Disease | pulmonary emphysema (implicated_via_orthology) | 1.61e-03 | 13 | 137 | 2 | DOID:9675 (implicated_via_orthology) | |
| Disease | heel bone mineral density, urate measurement | 1.64e-03 | 182 | 137 | 5 | EFO_0004531, EFO_0009270 | |
| Disease | lower face morphology measurement | 1.70e-03 | 109 | 137 | 4 | EFO_0010948 | |
| Disease | coronary artery disease, factor VII measurement | 1.81e-03 | 111 | 137 | 4 | EFO_0001645, EFO_0004619 | |
| Disease | factor VIII measurement, coronary artery disease | 1.94e-03 | 113 | 137 | 4 | EFO_0001645, EFO_0004630 | |
| Disease | Peripheral Nervous System Diseases | 2.04e-03 | 54 | 137 | 3 | C4721453 | |
| Disease | factor XI measurement, coronary artery disease | 2.06e-03 | 115 | 137 | 4 | EFO_0001645, EFO_0004694 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 2.27e-03 | 118 | 137 | 4 | EFO_0001645, EFO_0004629 | |
| Disease | creatinine measurement | LAMA5 SLC6A15 BTAF1 BIRC6 ADARB2 SLC47A2 RYR1 SLC7A9 RNF123 CELSR2 AP5B1 PKHD1 | 2.38e-03 | 995 | 137 | 12 | EFO_0004518 |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 2.46e-03 | 16 | 137 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | serum alanine aminotransferase measurement | NPC1 TRPM7 MFHAS1 LAMA5 GPAM ATP8B1 ITGA1 PTBP1 ATP10D CELSR2 NUP210 | 2.49e-03 | 869 | 137 | 11 | EFO_0004735 |
| Disease | hematocrit | SLC10A4 ATP8B1 ITGA1 PTBP1 ITGB6 EDNRA ARHGEF40 CNOT9 TBK1 PKHD1 ULK4 LRMDA | 2.71e-03 | 1011 | 137 | 12 | EFO_0004348 |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 2.76e-03 | 60 | 137 | 3 | C4722327 | |
| Disease | puberty onset measurement | 2.79e-03 | 125 | 137 | 4 | EFO_0005677 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 3.04e-03 | 128 | 137 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 3.04e-03 | 128 | 137 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 3.04e-03 | 128 | 137 | 4 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 3.04e-03 | 128 | 137 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 3.04e-03 | 128 | 137 | 4 | C0007134 | |
| Disease | risk-taking behaviour | NPC1 GABRG3 PRTG ERCC4 MFHAS1 TRPC6 TMEM63C CDH23 BIRC6 MAPRE3 | 3.07e-03 | 764 | 137 | 10 | EFO_0008579 |
| Disease | sweet liking measurement | 3.12e-03 | 18 | 137 | 2 | EFO_0010156 | |
| Disease | disease free survival | 3.12e-03 | 18 | 137 | 2 | EFO_0000409 | |
| Disease | response to bronchodilator, FEV/FEC ratio | 3.13e-03 | 766 | 137 | 10 | EFO_0004713, GO_0097366 | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 3.17e-03 | 63 | 137 | 3 | EFO_0001645, EFO_0004792 | |
| Disease | hydrocephalus (implicated_via_orthology) | 3.47e-03 | 19 | 137 | 2 | DOID:10908 (implicated_via_orthology) | |
| Disease | reticulocyte count | ABCB6 ITGA1 SLFN14 BIRC6 OR10T2 ADCY8 DOCK5 TBK1 DNAH17 PKD1 VPS13A SMG6 | 3.53e-03 | 1045 | 137 | 12 | EFO_0007986 |
| Disease | comparative body size at age 10, self-reported | 3.56e-03 | 420 | 137 | 7 | EFO_0009819 | |
| Disease | Prostate cancer, familial | 4.10e-03 | 69 | 137 | 3 | C2931456 | |
| Disease | smoking cessation | 4.20e-03 | 325 | 137 | 6 | EFO_0004319 | |
| Disease | BREAST CANCER | 4.24e-03 | 21 | 137 | 2 | 114480 | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 4.44e-03 | 71 | 137 | 3 | EFO_0001645, EFO_0004791 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 4.44e-03 | 71 | 137 | 3 | EFO_0007878, EFO_0007979 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VSGRIQVPEETYLIL | 1126 | P40145 | |
| YILVVPLIVINELDG | 1271 | Q86US8 | |
| EYVELLEVTLPVRGS | 241 | Q8TER5 | |
| VLVSVQSLILVAEPY | 4691 | Q9NR09 | |
| SPILENALVGQYVIT | 81 | Q96Q42 | |
| TYSVVQLPEEAVGLV | 386 | Q8WXI3 | |
| GTIAALLQEIVNIYP | 61 | Q92600 | |
| TSLVIPLIGEYLLFT | 321 | Q15822 | |
| YLVFNVIPTLADIII | 386 | Q9NP58 | |
| SLALGDLIYVVIDLP | 121 | P25101 | |
| VLASQEYLELLSPVV | 146 | Q4G176 | |
| TPYNIVLFLETLVEL | 256 | P51679 | |
| TVDVNLTYEIILTLG | 1041 | Q92625 | |
| QATVLESVPLGYLVL | 511 | Q9HCU4 | |
| QTIELLTLGQLLTYP | 1116 | Q96M86 | |
| IAETSLTIEGIIYVL | 676 | O60231 | |
| YGILVDPIQVVSLFL | 111 | O75907 | |
| VYSLILVASDLGQPV | 2686 | Q9H251 | |
| PISLYVSVEVIRLGQ | 401 | O43520 | |
| QVLIPISLYVSIELV | 376 | O94823 | |
| QVLIPISLYVSIEIV | 381 | Q9P241 | |
| TQIFYIPSTILLILE | 1106 | Q96QP1 | |
| LIGNVSIDSIIPYIL | 566 | P49116 | |
| IAQGSYIALPLTLLV | 1156 | P69849 | |
| VLISGTPIQNDLLEY | 321 | Q92698 | |
| VEPVYLQSIVVGSLH | 576 | Q9NS39 | |
| VTEYLEPVVLGTIIT | 466 | Q8N442 | |
| YIIQLLENSPVGTLL | 251 | Q9HCL0 | |
| ELLASIPAAVYVIAI | 291 | Q96EP9 | |
| IQADSPTLIIGEEYV | 236 | Q7L8S5 | |
| QEVEIHIPITLYPSI | 446 | Q8TEM1 | |
| IAQGSYIALPLTLLV | 1156 | Q5JPE7 | |
| VQLIEDYSLVSFIPL | 226 | Q9H9Y4 | |
| EVTPALEYLSLLGNV | 71 | Q9H2I8 | |
| IRYLPDSIVELTGLE | 331 | Q9Y4C4 | |
| IAALYIPESSQVIGL | 1896 | Q03001 | |
| LYVATVLQEPELNLT | 741 | Q9P1W3 | |
| LLVLETYNVPELSAG | 576 | Q9HCM2 | |
| VLEYPTIGQLIDKLV | 306 | P18564 | |
| TLPNVVYGLTAILLV | 191 | Q9H255 | |
| DSYIIEILIVVNSGI | 191 | Q8NGD3 | |
| IIYSLAEDTIQGVPL | 491 | Q9Y5H3 | |
| IAQGSYIALPLTLLV | 1156 | Q15155 | |
| IYLQTILGVPSLEEV | 196 | Q5TB30 | |
| LGPTIQAEVYDTVVI | 91 | P00451 | |
| VIQLLDTSYLLTPVA | 271 | Q2VPB7 | |
| EAEGVLLDYVVLLPS | 1001 | O15230 | |
| DLISSIPVDYIFLVV | 176 | Q9P1Z3 | |
| LDIVIVLDGSNSIYP | 171 | P56199 | |
| TLTELLALEPGVAYQ | 361 | Q9Y3T9 | |
| VGILIESLIVYEPTN | 86 | A0A2R8YFL7 | |
| VLATPVDIVILGLSY | 166 | O75694 | |
| LDIVVSGYVLQLQSP | 4986 | Q96RW7 | |
| DQLVAVTYTVVTPLL | 271 | Q8NGX3 | |
| VISVEENVPIGTLVY | 1516 | Q6V1P9 | |
| APEVALVDVNVYLII | 686 | Q9Y5I2 | |
| RITALPTGVLQIYDV | 181 | Q2VWP7 | |
| ILIKVQVYVSGELVP | 41 | A8MVW0 | |
| PAVEIIVILISNYGI | 811 | Q5T6X5 | |
| SYIGLPLTLIVIEVI | 676 | O15118 | |
| EPEEQLGTLQLLIYL | 496 | O43182 | |
| SIIPYFATLITELVQ | 311 | Q16322 | |
| VELSAPVLQEIYLSG | 21 | Q8TCG5 | |
| IEQVIVAEPGAVLLY | 361 | Q9Y2V7 | |
| VGTLIPLVYEQVEVQ | 1521 | Q13315 | |
| EVLAVYLQQIPDSTI | 206 | A0AVF1 | |
| ANIAYTPDIIIASIL | 2156 | Q9Y2F5 | |
| IILPGDVRNDIYVTL | 436 | Q9H7D0 | |
| AYPAQVVSLILSDVV | 231 | Q8IVS8 | |
| AASLVPVVESLVYLQ | 451 | O14981 | |
| VPEITVIQTILYLLE | 2316 | Q9UFH2 | |
| TVIDVDIYVNSIGPV | 71 | Q99928 | |
| PQTLVLYLLVLAVTE | 6 | Q96T91 | |
| TVPLIDVINGNTYEI | 326 | Q86SF2 | |
| IATIYIIPGDINSLV | 361 | P82251 | |
| ENTVLLLPGIYEIKT | 2521 | A8TX70 | |
| TTGIIEYPFDLENII | 186 | P29992 | |
| LSVLQDYIILPTITI | 76 | Q7Z7B8 | |
| VYILTTGLIPVLEKE | 151 | A0PJE2 | |
| VTLVALVDVDNYGPI | 531 | Q9Y653 | |
| LSVYTIPSIGLALLE | 401 | Q6GMR7 | |
| SVIPILGLIETSLYD | 2426 | Q99698 | |
| PVISGIIGILYATEE | 246 | Q9UPY8 | |
| LSEITYLGQPDISIL | 321 | Q8N6P7 | |
| VYLLLIQTDPLEGVN | 21 | Q14CZ8 | |
| GLRPLTEYQVTVIAL | 296 | Q02388 | |
| LPVGELLIETTEYSV | 1011 | Q8NDH2 | |
| ETLVLYALGVVLQDP | 361 | Q6UW02 | |
| GVAELIPLVTTYIIL | 281 | Q12770 | |
| PIEGVILSLQDLIIY | 436 | P21817 | |
| LEAGIYEVPIIITDS | 671 | P19022 | |
| YLTNVDDITLVPGTL | 376 | Q13822 | |
| LELYGILSVDPVLSI | 256 | Q9BTE3 | |
| YGINCLLTPVTVEIT | 596 | Q13029 | |
| VTYTPVAAGLLEIQV | 2026 | P98161 | |
| SIQDLVIALTYTVLP | 266 | A6ND48 | |
| LSTVNGVADPIIYVL | 296 | Q9UNW8 | |
| YSQLIILDLLVPVIG | 151 | Q8WU17 | |
| SEDLYPDINVITGIL | 461 | Q6ZW31 | |
| GIIPDLVIYLSDTEN | 651 | Q5TCS8 | |
| AAEIIIDIYLPVIGQ | 441 | Q8TED0 | |
| IDIYLPVIGQSPVVD | 446 | Q8TED0 | |
| VLDSEYLVTLLVVVP | 176 | P21283 | |
| DYSATLPLLIVVILE | 526 | Q9H2J7 | |
| VVYIEELQPVLTLEE | 326 | Q8N3R3 | |
| IAVNSPVVLYTILID | 461 | P0C7P3 | |
| EDVIALVSQVLPVYS | 401 | Q86VL8 | |
| VLYQGLVEILIPDVL | 686 | P22670 | |
| AVLAGIILSNVIPYL | 456 | Q96RN1 | |
| INDYREIITIPGVKI | 541 | Q96RN1 | |
| NILVYLVTSLLGVVP | 196 | Q8NG95 | |
| VDPQLYVTITISIII | 176 | Q8IYJ0 | |
| DILIIPVGISYDRII | 346 | Q9HCL2 | |
| NLLYVVLQGEEPIEI | 3541 | P08F94 | |
| EEGELILSVNILYPV | 176 | Q92966 | |
| ITYVPPLLLEVGVEE | 36 | Q96JT2 | |
| GQVTPLEIDILYQLA | 261 | O75746 | |
| YGLLSEAELEVVPII | 231 | Q15642 | |
| ETNPYLLALTIIVSI | 351 | O96005 | |
| AVTLIYQLAEGPEVI | 871 | Q15021 | |
| PFYEVLGLVTLEDVI | 486 | Q6P4Q7 | |
| TLPRVLEIQAGIYLE | 16 | Q8N1K5 | |
| SDLLSPILYVIQNEV | 421 | Q9HA65 | |
| TQPVEAVLEEIYLLI | 76 | Q96RL7 | |
| VYTIPAVLTLLVGLN | 36 | Q6QAJ8 | |
| LIVGILLVPQSIAYS | 116 | P50443 | |
| YPILVAVTGILVQLL | 1146 | Q5XPI4 | |
| ILELYQTGSTEPVEV | 696 | Q9H0D6 | |
| STIIQELEPGVEYFI | 676 | P24821 | |
| VLEVTYPGPAVVLDI | 551 | Q9BWH6 | |
| YSATLPLTLIVILEN | 526 | Q9H1V8 | |
| LLTPLATQLTYEGLI | 236 | Q96AX1 | |
| IEPVTLEVGDYILTP | 706 | Q92889 | |
| PQIISEGLYAIAVVL | 591 | Q9Y210 | |
| ISLGVAISNPDLVIY | 41 | B4DXR9 | |
| IIVENLFYPVTLDVL | 186 | P26599 | |
| VILTVLEYLQESPPV | 296 | Q96QT4 | |
| VVSREPLNTIGLIYE | 381 | Q9UHD2 | |
| DPQIISEGLYAIAVV | 521 | Q13507 | |
| GENLFILYLPSIVIT | 401 | Q7Z402 | |
| PTLGELIYLVATQEE | 576 | Q96C45 | |
| PQIISEGLYAIAVVL | 536 | Q9HCX4 | |
| VDTTYGVLLLLPVIA | 781 | Q9Y487 | |
| SVLGIIIYVTDLIVD | 11 | Q5GH70 |